Brief

US Again Urges High Court To Back Drug Price Program

By Mark Payne · April 9, 2026, 12:55 PM EDT

The administration of President Donald Trump again urged the Supreme Court not to hear a challenge to the Medicare drug price negotiation program, arguing against a constitutional challenge brought by Boehringer...

To view the full article, register now.

Documents

Case Information

Case Title

Boehringer Ingelheim Pharmaceuticals, Inc., Petitioner v. Department of Health and Human Services, et al.

Case Number

25-799

Court

Supreme Court

Nature of Suit

Date Filed

January 07, 2026